Abstract: In contrast to cardiomyocytes, autophagy in cardiac microvascular endothelial cells (CMECs) during ischemia/reperfusion (I/R) injury has not been fully investigated. Tongxinluo (TXL), a traditional Chinese medicine, was shown to be vascular protective. We aimed to elucidate the role of autophagy and its regulatory mechanisms by TXL in CMECs subjected to I/R injury. CMECs were exposed to different treatments for 30 minutes and subjected to hypoxia/reoxygenation each for 2 hours. The results indicated that hypoxia/reoxygenation significantly induced autophagy, as identified by an increased number of monodansylcadaverine-positive CMECs, increased autophagosome formation, and a higher type II/type I of light chain 3 ratio, but not Beclin-1 expression. Autophagy inhibition using 3-methyladenine was proapoptotic, but rapamycin-induced autophagy was antiapoptotic. TXL enhanced autophagy and decreased apoptosis in a dose-dependent manner, reaching its largest effect at 800 mg/mL. 3-methyladenine attenuated the TXL-promoted autophagy and antiapoptotic effects, whereas rapamycin had no additional effects compared with TXL alone. TXL upregulated mitogen-activated protein kinase and extracellular signal-regulated kinase (ERK) phosphorylation; however, PD98059 abrogated ERK phosphorylation and decreased autophagy and increased apoptosis compared with TXL alone. These results suggest that autophagy is a protective mechanism in CMECs subjected to I/R injury and that TXL can promote autophagy through activation of the mitogenactivated protein kinase/ERK pathway.
INTRODUCTION
Myocardial ischemia/reperfusion injury, which represents the death of the myocardium after reperfusion therapy, is the primary reason for retained mortality despite optimal revascularization. 1 Microvascular disturbance is a vital feature of myocardial reperfusion injury. 2 Cardiac microvascular endothelial cells (CMECs) are the most common cells in a normal heart that constitute a basic component of the myocardial microcirculation, secreting cytokines involved in cardiac metabolism, growth, contractile performance, and rhythmicity under normal conditions. 3 Moreover, CMECs play important roles in the preservation of cardiomyocytes (CMs) against reperfusion injury through paracrine or autocrine mechanisms, such as through nitric oxide 4 and neuregulin. 5 When the cardiac microcirculation is restored after a period of ischemia, CMECs are first harmed by reperfusion injury, followed by CMs. Studies have indicated that endothelial cells are more vulnerable to reperfusion injury but that CMs are more sensitive to ischemic injury. 6, 7 However, the protection of endothelial cells against reperfusion injury has received much less attention than CMs or the myocardium, as indicated by PubMed searches ("myocardial" or "cardiomyocyte" and "reperfusion injury," 14,207 articles vs. "cardiac" and "endothelial" and "reperfusion injury," 759 articles).
Autophagy (more precisely, macroautophagy) is a lysosome-dependent catabolic process that disposes of damaged or dysfunctional organelles and protein aggregates. Autophagy is considered an accurately orchestrated mechanism that is involved in the maintenance of intracellular homeostasis. 8 Dysregulation of autophagy exists in the process of many cardiovascular diseases, such as cardiomyopathy, 9 heart failure, 10 atherosclerosis, 11 and myocardial ischemia/reperfusion injury. 12 Autophagy can be induced by both ischemia and reperfusion and can have prosurvival or proapoptotic functions in diverse cell types and in different environments. 13 To date, the role of autophagy in myocardial reperfusion injury remains controversial. Autophagy has been reported to exert a protective function during ischemia but a detrimental function during reperfusion. 14 The mitogen-activated protein kinase (MEK) and extracellular signal-regulated kinase (ERK) pathway is involved in various cellular processes, such as cell proliferation and differentiation, cell death and survival, and cell motility, in different cell types. 15, 16 However, the regulatory mechanism of the MEK/ERK pathway in autophagy remains unclear.
Tongxinluo (TXL) is a traditional Chinese medicine formulation that has been approved for the market by the China State Food and Drug Administration in 1996.
The formulation consists of extractions or powders from Radix ginseng, Buthus martensi, Hirudo, Eupolyphaga seu steleophaga, Scolopendra subspinipes, Periostracum cicadae, Radix paeoniae rubra, Semen ziziphi spinosae, Lignum dalbergiae odoriferae, Lignum santali albi, and Borneolum syntheticum.
17 TXL is currently widely used by more than 6 million patients with cardio-cerebrovascular diseases in China for its beneficial effects against vascular diseases, including atherosclerosis, 18, 19 angina pectoris, 20 myocardial infarction, 21 and no-reflow phenomenon. 22, 23 The major ingredients of TXL included peoniflorin, ginsenoside Rg1, ginsenoside Rb1, jujuboside A, jujuboside B, isoborneol, and borneol according to the results of high-performance liquid chromatography (HPLC) and gas chromatography. 19 Our previous studies have confirmed that TXL reduces myocardial noreflow and reperfusion injury through the preservation of endothelial nitric oxide synthase (eNOS) activity, 23, 24 but the mechanisms regarding its protection of CMECs remain unknown. Therefore, we used an in vitro model of CMEC ischemia/reperfusion injury to understand the role of autophagy and its regulation by TXL during hypoxia/reoxygenation (H/R).
MATERIALS AND METHODS

Preparation of the TXL Solution
A solution of TXL ultrafine powder (Lot Number: 071201; Shijiazhuang Yiling Pharmaceutical Co., Shijiazhuang, China) was prepared as previously described with a minor modification. 25 Briefly, the powder was dissolved in serum-free Dulbecco's modified Eagle's medium (DMEM; Life Technologies, Grand Island, NY), and the suspension was sonicated for 30 minutes followed by centrifugation at 2500 rpm for 15 minutes. The supernatant was filtered through a 0.22-mm micro-pore filter, and the precipitate was dried at 608C in an oven to calculate the exact weight of the dissolved TXL powder. The solution was adjusted to a final concentration of 2 mg/mL through the addition of DMEM and was then stored at 2208C for subsequent use.
Cell Culture and Treatments
Human CMECs were purchased from ScienCell Research Laboratories (San Diego, CA) and were cultured according to the manufacturer's instructions. They were characterized by the immunofluorescent method using antibodies directed against vWF (Factor VIII) and CD31 (PECAM-1) and by uptake of DiI-Ac-LDL. The cells were grown in endothelial cell medium (ScienCell Research Laboratories) containing 5% fetal bovine serum (ScienCell Research Laboratories), 1% endothelial cell growth supplement (ScienCell Research Laboratories), and 1% penicillin/streptomycin at 378C with 5% CO 2, and they were subcultured at a ratio of 1:3 when reached 90% confluence. Cells in passage 3 or 4 were washed with phosphate-buffered saline (PBS) and exposed to different treatments in serum-free DMEM 30 minutes before hypoxia. The cells were incubated in a sealed, hypoxic GENbox jar fitted with a catalyst (BioMérieux, Marcy l'Etoile, France) to scavenge free oxygen for 2 hours of hypoxia and were then moved to normal conditions for 2 hours of reoxygenation. The oxygen tension in the medium was measured using an anaerobic indicator (BioMérieux). The TXL solution was adjusted to different concentrations (100, 200, 400, 800, and 1200 mg/mL) to determine the optimal working concentration. Ginsenoside Rg1 (Sigma-Aldrich, St. Louis, MO) and paeoniflorin (PF) (Sigma-Aldrich) were used to investigate the effects of major active components in TXL. Ginsenoside Rg1 at the range of 5-20 mM, 26 PF at the range of 40-1000 mM 27,28 were used as previously published. 3-methyladenine (3-MA) was used as autophagy inhibitor, and rapamycin was used as autophagy promoter as before. 13, 29 3-MA (Sigma-Aldrich) at 5 mM, 30 rapamycin (Sigma-Aldrich) at 100 nM, 31 and the MEK inhibitor PD98059 (Selleckchem, Houston, TX) at 50 mM 32 as previously described were used to further investigate the role and the modulatory mechanism of autophagy in CMECs.
Determination of Apoptosis Using Flow Cytometry
Cell apoptosis was assessed using the Annexin V-FITC/ PI Kit (Biosea Biotechnology, Beijing, China) according to the manufacturer's instructions. Briefly, the cells were harvested and resuspended in 500 mL of medium buffer. Five microliters of annexin V solution was added to the cell suspension solution. The mixture was incubated for 15 minutes at room temperature in the dark. Subsequently, 5 mL of propidium iodide (PI) was added, and 15,000 cells were acquired and immediately analyzed using the FACS Calibur System (Becton-Dickinson). The cells were classified into 4 quadrants: viable cells (annexin V2/PI2), early apoptotic cells (annexin V+/PI2), late apoptotic cells (annexin V+/PI+), and necrotic cells (annexin V2/PI+). Apoptotic rates were calculated by summing the early and late apoptotic quadrants and were compared among the different groups.
Detection of Autophagosomes Using Transmission Electron Microscopy
After the treatments, the cells were collected and fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer at 48C for 3 hours. The cells were then washed with PBS and postfixed with 1% osmic acid at 48C for an additional 1.5 hours. Thereafter, the cells were dehydrated with a serial ethanol gradient and embedded in Embed-812 medium (Electron Microscopy Sciences, Hatfield, PA). Ultrathin sections were cut using an ultratome (Leica, Solms, Germany) on uncoated copper grids and were stained with 0.2% lead citrate/1% uranyl acetate. Images at different magnifications (·6000 and ·16,500) were recorded using a transmission electron microscope (JEOL, Tokyo, Japan).
Evaluation of Autophagy Using Monodansylcadaverine Fluorescence Detection
observed immediately using fluorescence microscopy at an excitation wavelength of 335 nm and an emission wavelength of 525 nm (Leica). For the quantitative analysis, 5 random fields at ·200 magnification of each group were captured. After washing, the membranes were incubated with peroxidase-conjugated secondary antibodies at 1:5000. Subsequently, the membranes were washed and processed for analysis using a Chemiluminescence Detection Kit (Pierce) as described by the manufacturer. Target signals were semiquantitatively analyzed using the Quantity One system.
Protein Preparation and Western Blot Analysis
Statistical Analysis
Qualitative data were collected from at least 3 experimental groups and are expressed as the mean 6 standard error of the mean. The statistical analysis was conducted using GraphPad Prism software (Version 5.01, GraphPad Software, La Jolla, CA). Differences among the groups were evaluated using 1-way analysis of variance. Significant differences between the 2 groups were determined using 2-tailed unpaired Student's t test. A value of P , 0.05 was considered significant.
RESULTS
TXL Inhibited Ischemia/Reperfusion-induced Apoptosis of CMECs In Vitro
We used a model of acute reperfusion injury (2 hours of hypoxia followed by 2 hours of reoxygenation) to induce the apoptosis of CMECs, as previously described. 33, 34 To investigate whether TXL can protect CMECs from apoptosis in vitro, CMECs were exposed to different TXL concentrations (100, 200, 400, 800, and 1200 mg/mL) for 30 minutes before H/R. Flow cytometric assays indicated that the H/R exposure significantly increased the apoptotic rate of CMECs in comparison with the normal group (21.04% 6 1.11% vs. 6.17% 6 0.75%, P , 0.0001; Fig. 1A ). TXL attenuated H/R-induced apoptosis in a dose-dependent manner and reached its peak benefit at 800 mg/mL, which reduced apoptotic cells to 9.92% 6 0.49% under H/R conditions (P , 0.0001; Fig. 1A) . Correspondingly, the Western blot analysis indicated that Bcl-2 expression was weakened by H/R in comparison with normal conditions (0.75 6 0.10 vs. 1.16 6 0.09, P = 0.0404) but was enhanced by TXL at 800 mg/mL (1.25 6 0.14, P = 0.0413); in contrast, Bax and cytochrome c expression were inversely proportional to Bcl-2 expression (Fig. 1B) . Thus, TXL protected CMECs from acute reperfusion-induced apoptosis in vitro.
Autophagy Protected CMECs Against H/R-induced Apoptosis
Autophagy has been reported to be protective in several other endothelial cell lines under short-term hypoxia or chemically induced oxidative stress. [17] [18] [19] [20] In our study, the Fig. 3B ) than H/R alone. Conversely, the autophagy inducer rapamycin attenuated apoptosis (11.27 6 1.44 vs. 17.04 6 1.06, P = 0.0212; Fig. 3A) , elevated Bcl-2 expression, and reduced the levels of Bax and cytochrome c compared with the H/R group (Fig. 3B) . These results indicated that autophagy functioned as a protective mechanism against the apoptosis of CMECs.
TXL Promoted Autophagy in CMECs During H/R
To evaluate whether TXL is able to modulate autophagy in CMECs under H/R, the cells were treated with different concentrations of TXL as previously mentioned and then subjected to H/R. As shown in Figure 4A , MDCpositive CMECs that were identified using fluorescence microscopy gradually increased in the TXL-treated groups in a dose-dependent manner, and the MDC-positive rate in the group treated with 800 mg/mL TXL was significantly higher than that in the H/R group (56.40 6 2.73 vs. 35.00 6 4.52, P = 0.0037). We also found that the group treated with 800 mg/mL TXL exhibited a larger LC3-II/LC3-I ratio than the H/R group (1.38 6 0.16 vs. 0.81 6 0.11, P = 0.024; Fig. 4B ). However, the expression of another autophagic marker, Beclin-1, was not elevated as expected (Fig. 4B) . These results indicated that TXL promoted autophagy in CMECs in a dose-dependent manner under H/R conditions.
Autophagy in CMECs Participated in the Antiapoptotic Mechanisms of TXL
We used 3-MA and rapamycin to confirm that TXL-promoted autophagy played an antiapoptotic role in CMECs. As shown in Figure 5 (Fig. 5C ) in the CMECs treated with 800 mg/mL TXL under H/R conditions, but the combination with rapamycin did not further increase any of these outcomes (Figs. 5A-C) . These results indicated that TXL may share identical mechanisms with rapamycin in the activation of autophagy. As expected, the addition of 3-MA increased apoptosis in comparison with the 800 mg/mL TXL group (13.00 6 1.87 vs. 7.15 6 0.69, P = 0.0208), whereas rapamycin did not reduce apoptosis further in the presence of TXL (Fig. 5D) . These results suggested that upregulated autophagic activity may partially explain the protective mechanism of TXL against H/Rinduced CMEC apoptosis. (Fig. 6C) . Thus, ginsenoside Rg1 and PF might be part of the active components in TXL to induce autophagy.
TXL Activated Autophagy in CMECs Through the MEK/ERK Pathway
To determine the regulatory mechanisms of TXL involved in autophagy in CMECs, the MEK/ERK inhibitor PD98059 was added to cultures 30 minutes before the TXL and H/R treatments. As shown in Figure 7A , phosphorylated MEK and ERK were significantly increased in the TXLtreated group, and the phosphorylation of ERK was clearly abrogated by PD98059 in comparison with the TXL group. Moreover, in contrast to the 800 mg/mL TXL group, PD98059 reduced the autophagic activity, which was indicated by fewer MDC-positive cells (30.00 6 1.87 vs. 54.25 6 3.79, P = 0.0005; Fig. 8A ), a lower LC3-II/LC3-I ratio (0.83 6 0.15 vs. 1.79 6 0.14, P = 0.0093; Fig. 8B ), and the downregulation of autophagosome formation (Fig. 8C) . Accordingly, PD98059 attenuated the protective effects of 800 mg/mL TXL on the H/R-induced cell apoptosis rate (12.19 6 1.64 vs. 7.15 6 0.68, P = 0.0298; Fig. 7B ). These results demonstrated that TXL attenuated the H/R-induced apoptosis of CMECs by activating autophagy through the MEK/ERK pathway.
DISCUSSION
Our study used a previously adopted acute in vitro CMEC ischemia/reperfusion injury model (2 hours/2 hours) to understand the role of autophagy and its modulation by TXL. The results indicated the following: (1) autophagy was antiapoptotic rather than proapoptotic in CMECs during the acute H/R period and (2) the traditional Chinese medicine TXL protected CMECs from H/R-induced apoptosis in a dose-dependent manner at concentrations less than 1200 mg/mL, partially by promoting autophagy through the MEK/ ERK pathway. To the best of our knowledge, this study is the first investigation of autophagy in CMECs during ischemia/ reperfusion injury.
CMECs outnumber CMs by 3:1, although the mass ratio of CMEC-to-CM is only 0.04-0.05. Besides, a capillary is next to almost every CM, and the distance between these 2 types of cells are very short (approximately 1-2 mm).
3,6
CMECs not only constitute the most important part of the microcirculation by supplying nutrition and oxygen but also possess unique CM-protective functions through HIF-a/ eNOS activation and neuregulin secretion during myocardial reperfusion injury. 4, 35 Our study focused on the preservation of CMECs, or microcirculation protection in vitro, rather than CM protection itself. A few previous studies investigated the mechanisms in the endothelium that was subjected to ischemia/reperfusion injury using a human umbilical endothelial cell (HUVEC) model, but microvascular endothelial cells differ from large vessel endothelial cells in shape and size and in their response to stress stimulation. 36 Although we did not compare the apoptotic rate of the CMEC model with that of the HUVEC model, our study demonstrated that CMEC apoptosis was induced by H/R. Therefore, this model may have simulated practical myocardial microcirculation reperfusion injury better than the HUVEC model.
Autophagy is an intracellular process that eliminates old or destroyed organelles to recycle long-lived proteins, and it occasionally also induces cell death, which is called type II programmed cell death. In some in vitro studies using CMs or cardiomyoblasts experiencing short-term H/R, autophagy was found to be proapoptotic. 37, 38 However, autophagy was also considered protective in other studies, and its upregulation can reduce myocardial reperfusion injury. 39, 40 Because of the different sensitivities to hypoxia and reoxygenation between CMECs and CMs, estimating the role of autophagy in CMECs based on reports using CMs is difficult. This study demonstrated that autophagy could be induced by short-term H/R and could be antiapoptotic in CMECs. Our results are also supported by similar studies; for example, autophagy induction was also considered prosurvival under oxidative stress conditions induced by Ox-LDL. 41 Autophagy was recently reported to always function as a "double-edged sword" in HUVECs under hypoxic conditions, which indicated that short-term hypoxia-induced autophagy is FIGURE 7 . TXL increased phosphorylated MEK and ERK and accordingly decreased the apoptotic rate, whereas the addition of PD98059 decreased phosphorylated ERK and increased the apoptotic rate. A, Western blot analysis of MEK, ERK, and their phosphorylated forms. B, Apoptotic rates that were determined using flow cytometry. The values represent the mean 6 standard error of the mean. #P , 0.05 versus the normal group; *P , 0.05 versus the H/R group; $P , 0.05 versus the H/R + TXL (800 mg/mL) group.
antiapoptotic but that excess autophagy that is mediated by long-term anoxia is harmful. 42 These findings indicate that the role of autophagy in long-term H/R requires further investigation.
Interestingly, in our study, Beclin-1 expression was upregulated by H/R exposure, although this increase was not statistically significant, and the modulation of autophagy by TXL did not alter Beclin-1 expression. Beclin-1 participates in both the induction and the sequestration of the autophagy process, and its expression can be affected by many factors. 40 Beclin-1 has been shown to interact with Bcl-2/Bcl-x L , and Bcl-2 downregulation has been shown to increase autophagy in HL-60 cells, 43 indicating that the increased Bcl-2 observed in our study may interact with Beclin-1. Additionally, Zhang et al 30 reported that short-term hypoxia in mesenchymal stem cells did not affect the change in Beclin-1, and thus, a longer H/R process is warranted to confirm whether Beclin-1 participates in CMEC autophagy.
The MEK/ERK pathway is a universally recognized classical mechanism in the prevention and treatment of myocardial ischemia/reperfusion injury using many therapeutics, such as statins, insulin-like growth factor, and ischemic postconditioning. 44, 45 There are many targets for the MEK/ ERK pathway that are related to cell survival, including eNOS, apoptotic proteins (Bad, Bax, Bim, and caspases), and p70S6K. 45 Recently, the activation of MEK/ERK was also found to induce autophagy in NRK52E cells. 46 Using the MEK/ERK inhibitor PD98059, herein, we directly demonstrated that autophagy could be induced by MEK/ERK activation in endothelial cells, thereby providing new evidence on the regulation of autophagy in a different cell type.
TXL is a traditional Chinese medicine that is composed of extractions or powders from various natural products. Accumulating studies indicate that endothelium preservation is one of the mechanisms related to the cardiovascular protective effects of TXL. 21, 25, 47 Our previous studies have demonstrated that TXL counters myocardial reperfusion injury through the activation of the PKA/CREB/eNOS pathway 23 and protects endothelial connections through the promotion of VE-cadherin expression in the reflow area. 24 TXL was reported to protect HUVECs against ischemic injury by activating the PI3K/AKT/HIF-a signaling pathway. 25 We demonstrated in this study that TXL protected CMECs against reperfusion injury through the induction of autophagy and partially through the activation of MEK/ERK, which is another protective mechanism in RISK pathways in addition to PI3K/AKT. Although TXL is a medication that is formulated from many natural products and may acquire its functional properties after complicated metabolic processes in vivo, several ex vivo experiments have indicated that the TXL solution has a direct protective effect on diverse cell types. 25, 48 Ginsenoside Rg1 is one of components in TXL based on the result of HPLC. The chemical was showed to be protective against reperfusion injury using the model of CMs, 49, 50 and it was able to increase endothelial cell viability under oxidative condition. 51 Some other major ingredients of TXL such as peoniflorin and borneol were also demonstrated to have many beneficial effects, for example, attenuating reperfusion injury and protecting endothelial cells. 28, [52] [53] [54] [55] In this study, we proved that ginsenoside Rg1 and PF promoted autophagy in CMECs individually or in combination, which may partly elucidate the protective mechanisms of TXL against ischemia/reperfusion injury.
A major limitation of this study is that we could not demonstrate autophagy flux regulation by TXL, although we found the accumulation of autophagosomes in CMECs.
Another weakness of this study is whether the serum TXL concentration in patients is capable of inducing the autophagy that was observed in our in vitro studies. We found that preconditioning of TXL at the dose of 0.05 g/kg in the ischemia/reperfusion model of swine can reach similar effects such as reduced apoptosis of myocardial cells, increased Bcl-2, and suppressed Bax. 56 Nevertheless, Further studies are required to address these issues.
CONCLUSIONS
We reveal for the first time that autophagy serves as a protective mechanism in CMECs undergoing ischemia/ reperfusion injury and that TXL can promote autophagy by activating the MEK/ERK pathway. This report provides new insights into microcirculation preservation in myocardial reperfusion injury.
